阻断-话题@MedSci

#阻断#

363篇内容 | 2472人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1710260, encodeId=178d1e102602c, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Clin Cancer Res：SHP2抑制剂TNO155通过阻断RTK信号可增强多种靶向药的疗效, objectType=article, longId=202046, objectId=a60c20204663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a60c20204663, replyNumber=0, likeNumber=46, createdTime=2021-04-18, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a60c20204663, moduleTitle=Clin Cancer Res：SHP2抑制剂TNO155通过阻断RTK信号可增强多种靶向药的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a60c20204663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710280, encodeId=47c11e1028081, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Eur Urol Oncol：雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌, objectType=article, longId=212395, objectId=fb5e21239575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb5e21239575, replyNumber=0, likeNumber=79, createdTime=2021-11-27, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb5e21239575, moduleTitle=Eur Urol Oncol：雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb5e21239575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710273, encodeId=a6e41e10273ca, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Sci Rep：循环肿瘤DNA作为转移性肾细胞癌中免疫检查点阻断治疗反应的预测因子表现研究, objectType=article, longId=208521, objectId=ca8a20852107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca8a20852107, replyNumber=0, likeNumber=80, createdTime=2021-12-06, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca8a20852107, moduleTitle=Sci Rep：循环肿瘤DNA作为转移性肾细胞癌中免疫检查点阻断治疗反应的预测因子表现研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca8a20852107)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710244, encodeId=77df1e10244d3, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Ann Rheum Dis：重症新冠肺炎炎症风暴使用sarilumab阻断白介素-6的疗效, objectType=article, longId=197867, objectId=26d719e867cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26d719e867cc, replyNumber=0, likeNumber=56, createdTime=2020-10-19, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26d719e867cc, moduleTitle=Ann Rheum Dis：重症新冠肺炎炎症风暴使用sarilumab阻断白介素-6的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26d719e867cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710251, encodeId=47b21e10251e0, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=J Invest Dermatol：Dupilumab对IL-4Rα的阻断作用可降低特应性皮炎患者皮肤上金葡菌的定植并增加微生物的多样性, objectType=article, longId=199626, objectId=d462199626d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d462199626d8, replyNumber=0, likeNumber=119, createdTime=2020-11-03, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d462199626d8, moduleTitle=J Invest Dermatol：Dupilumab对IL-4Rα的阻断作用可降低特应性皮炎患者皮肤上金葡菌的定植并增加微生物的多样性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d462199626d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710268, encodeId=620b1e10268f7, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Cell Death Dis：阻断EIF5A的hypusination作用可抑制结直肠癌细胞的生长, objectType=article, longId=204918, objectId=5bfd204918e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bfd204918e2, replyNumber=0, likeNumber=59, createdTime=2021-09-28, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bfd204918e2, moduleTitle=Cell Death Dis：阻断EIF5A的hypusination作用可抑制结直肠癌细胞的生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bfd204918e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710275, encodeId=a9e21e1027549, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Nat Med：经典霍奇金淋巴瘤患者PD-1阻断反应性的外周免疫特征, objectType=article, longId=209762, objectId=a266209e627b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a266209e627b, replyNumber=0, likeNumber=69, createdTime=2021-06-22, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a266209e627b, moduleTitle=Nat Med：经典霍奇金淋巴瘤患者PD-1阻断反应性的外周免疫特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a266209e627b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710263, encodeId=16aa1e102634e, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=孙春兰强调：以刻不容缓的战时状态阻断疫情扩散蔓延, objectType=article, longId=203022, objectId=081e203022b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=081e203022b7, replyNumber=0, likeNumber=80, createdTime=2021-04-09, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=081e203022b7, moduleTitle=孙春兰强调：以刻不容缓的战时状态阻断疫情扩散蔓延, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=081e203022b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710267, encodeId=7e3d1e10267bf, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=创新性SARS-CoV-2阻断剂可完全防止细胞感染, objectType=article, longId=204373, objectId=616f2043e3df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616f2043e3df, replyNumber=0, likeNumber=60, createdTime=2021-10-12, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616f2043e3df, moduleTitle=创新性SARS-CoV-2阻断剂可完全防止细胞感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=616f2043e3df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710270, encodeId=0d3e1e10270b3, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=J Clin Oncol：Abatacept协同刺激阻断可明显有效预防急性GVHD！, objectType=article, longId=206294, objectId=1ff32062949d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff32062949d, replyNumber=0, likeNumber=69, createdTime=2021-10-06, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff32062949d, moduleTitle=J Clin Oncol：Abatacept协同刺激阻断可明显有效预防急性GVHD！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ff32062949d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710262, encodeId=36291e102627a, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Nat Med：不适合顺铂治疗的高风险尿路上皮癌患者的新辅助PD-L1加CTLA-4阻断疗法, objectType=article, longId=202749, objectId=c7e3202e494d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7e3202e494d, replyNumber=0, likeNumber=75, createdTime=2021-03-26, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7e3202e494d, moduleTitle=Nat Med：不适合顺铂治疗的高风险尿路上皮癌患者的新辅助PD-L1加CTLA-4阻断疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7e3202e494d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710272, encodeId=a6031e1027285, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Eur Urol：雄激素受体剪接变异体7可预测接受雄激素阻断治疗转移激素敏感性前列腺癌患者的较短响应 , objectType=article, longId=208276, objectId=c5c32082e607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5c32082e607, replyNumber=0, likeNumber=60, createdTime=2021-10-31, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5c32082e607, moduleTitle=Eur Urol：雄激素受体剪接变异体7可预测接受雄激素阻断治疗转移激素敏感性前列腺癌患者的较短响应 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5c32082e607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710242, encodeId=92431e10242a6, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=PNAS：新突破：阻断一种蛋白可抑制肝癌和胆管癌, objectType=article, longId=197119, objectId=823c19e11933, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823c19e11933, replyNumber=0, likeNumber=85, createdTime=2020-08-19, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823c19e11933, moduleTitle=PNAS：新突破：阻断一种蛋白可抑制肝癌和胆管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=823c19e11933)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710256, encodeId=da141e10256a3, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Nat Commun：双重阻断CD47和HER2能消除乳腺癌细胞的放疗抗性, objectType=article, longId=200793, objectId=70b2200e93d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70b2200e93d1, replyNumber=0, likeNumber=83, createdTime=2021-07-07, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70b2200e93d1, moduleTitle=Nat Commun：双重阻断CD47和HER2能消除乳腺癌细胞的放疗抗性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70b2200e93d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710258, encodeId=dd8d1e102581b, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Clin Cancer Res：转移性去势抵抗性前列腺癌c-MET和雄激素受体双重阻断:恩扎鲁胺和克唑替尼联合应用的一期研究, objectType=article, longId=201364, objectId=cf922013647f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf922013647f, replyNumber=0, likeNumber=80, createdTime=2021-02-21, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf922013647f, moduleTitle=Clin Cancer Res：转移性去势抵抗性前列腺癌c-MET和雄激素受体双重阻断:恩扎鲁胺和克唑替尼联合应用的一期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf922013647f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710261, encodeId=4f741e1026189, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Eur Urol：有无放疗的雄激素阻断治疗原发性转移前列腺癌患者的生活质量, objectType=article, longId=202313, objectId=521b202313e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=521b202313e2, replyNumber=0, likeNumber=60, createdTime=2021-03-02, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=521b202313e2, moduleTitle=Eur Urol：有无放疗的雄激素阻断治疗原发性转移前列腺癌患者的生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=521b202313e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710243, encodeId=78d21e102435d, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, objectType=article, longId=197668, objectId=c43e19e6680f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c43e19e6680f, replyNumber=0, likeNumber=68, createdTime=2021-05-16, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c43e19e6680f, moduleTitle=白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c43e19e6680f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710245, encodeId=2fe31e10245e1, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=J Biol Chem：阻断致命的细胞因子风暴是治疗COVID-19的重要武器, objectType=article, longId=198074, objectId=83451980e4fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83451980e4fd, replyNumber=0, likeNumber=64, createdTime=2020-09-11, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83451980e4fd, moduleTitle=J Biol Chem：阻断致命的细胞因子风暴是治疗COVID-19的重要武器, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83451980e4fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710230, encodeId=54801e1023000, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应 , objectType=article, longId=192841, objectId=60cc192841a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60cc192841a6, replyNumber=0, likeNumber=87, createdTime=2020-07-29, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60cc192841a6, moduleTitle=Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60cc192841a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1710238, encodeId=1ea61e10238c4, content=<a href='/topic/show?id=7ac59e67604' target=_blank style='color:#2F92EE;'>#阻断#</a>, objectTitle=J Clin Oncol：局部前列腺癌体外放射治疗中加入雄激素阻断治疗或者近距离放射治疗研究 , objectType=article, longId=195428, objectId=38a3195428ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38a3195428ae, replyNumber=0, likeNumber=71, createdTime=2020-10-19, rootId=0, userName=41514497@qq.com, userId=b5ca31824852, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38a3195428ae, moduleTitle=J Clin Oncol：局部前列腺癌体外放射治疗中加入雄激素阻断治疗或者近距离放射治疗研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38a3195428ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阻断

2020-05-29

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Clin Cancer Res：SHP2抑制剂TNO155通过阻断RTK信号可增强多种靶向药的疗效

2021-04-18

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Eur Urol Oncol：雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌

2021-11-27

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Sci Rep：循环肿瘤DNA作为转移性肾细胞癌中免疫检查点阻断治疗反应的预测因子表现研究

2021-12-06

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Ann Rheum Dis：重症新冠肺炎炎症风暴使用sarilumab阻断白介素-6的疗效

2020-10-19

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

J Invest Dermatol：Dupilumab对IL-4Rα的阻断作用可降低特应性皮炎患者皮肤上金葡菌的定植并增加微生物的多样性

2020-11-03

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Cell Death Dis：阻断EIF5A的hypusination作用可抑制结直肠癌细胞的生长

2021-09-28

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Nat Med：经典霍奇金淋巴瘤患者PD-1阻断反应性的外周免疫特征

2021-06-22

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

孙春兰强调：以刻不容缓的战时状态阻断疫情扩散蔓延

2021-04-09

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

创新性SARS-CoV-2阻断剂可完全防止细胞感染

2021-10-12

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

J Clin Oncol：Abatacept协同刺激阻断可明显有效预防急性GVHD！

2021-10-06

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Nat Med：不适合顺铂治疗的高风险尿路上皮癌患者的新辅助PD-L1加CTLA-4阻断疗法

2021-03-26

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Eur Urol：雄激素受体剪接变异体7可预测接受雄激素阻断治疗转移激素敏感性前列腺癌患者的较短响应

2021-10-31

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

PNAS：新突破：阻断一种蛋白可抑制肝癌和胆管癌

2020-08-19

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Nat Commun：双重阻断CD47和HER2能消除乳腺癌细胞的放疗抗性

2021-07-07

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Clin Cancer Res：转移性去势抵抗性前列腺癌c-MET和雄激素受体双重阻断:恩扎鲁胺和克唑替尼联合应用的一期研究

2021-02-21

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Eur Urol：有无放疗的雄激素阻断治疗原发性转移前列腺癌患者的生活质量

2021-03-02

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

白介素-1阻断剂Rilonacept治疗心包炎，获得FDA授予孤儿药称号

2021-05-16

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

J Biol Chem：阻断致命的细胞因子风暴是治疗COVID-19的重要武器

2020-09-11

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

Nat Commun：前列腺特异性抗原动态能够预测个体对间歇性雄激素阻断治疗的个体响应

2020-07-29

41514497@qq.com (审核中...)

前往app查看评论内容

#阻断#

J Clin Oncol：局部前列腺癌体外放射治疗中加入雄激素阻断治疗或者近距离放射治疗研究

2020-10-19

科室
- - 订阅+
  - 更多科室
工具
服务